From PCOS to PMOS: How this name change is set to improve care
Posted:
A global expert panel has recently announced that the condition hitherto known as polycystic ovary syndrome (PCOS) will officially undergo a name change to polyendocrine metabolic ovarian syndrome (PMOS).
Previously, doctors would diagnose the condition formerly known as PCOS based on the presence of fluid-filled cysts on a person’s ovaries.
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek,…
WhatsApp has introduced private chats with its AI chatbot which not even the tech company will be able to read in a new "incognito" mode.
The technology behind WhatsApp's incognito mode is not the same as the end-to-end encryption the platform uses…
Attendees
Sponsors and Exhibitors
Contact us